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GABAB receptors are heterodimeric G-protein coupled receptors known to be involved
in learning and memory. Although a role for GABAB receptors in cognitive processes
is evident, there is no information on hippocampal GABAB receptor complexes
in a multiple T maze (MTM) task, a robust paradigm for evaluation of spatial
learning. Trained or untrained (yoked control) C57BL/6J male mice (n = 10/group)
were subjected to the MTM task and sacrificed 6 h following their performance.
Hippocampi were taken, membrane proteins extracted and run on blue native PAGE
followed by immunoblotting with specific antibodies against GABAB1, GABAB1a, and
GABAB2. Immunoprecipitation with subsequent mass spectrometric identification of
co-precipitates was carried out to show if GABAB1 and GABAB2 as well as other
interacting proteins co-precipitate. An antibody shift assay (ASA) and a proximity ligation
assay (PLA) were also used to see if the two GABAB subunits are present in the receptor
complex. Single bands were observed on Western blots, each representing GABAB1,
GABAB1a, or GABAB2 at an apparent molecular weight of approximately 100 kDa.
Subsequently, densitometric analysis revealed that levels of GABAB1 and GABAB1a
but not GABAB2- containing receptor complexes were significantly higher in trained
than untrained groups. Immunoprecipitation followed by mass spectrometric studies
confirmed the presence of GABAB1, GABAB2, calcium calmodulin kinases I and II, GluA1
and GluA2 as constituents of the complex. ASA and PLA also showed the presence of
the two subunits of GABAB receptor within the complex. It is shown that increased levels
of GABAB1 subunit-containing complexes are paralleling performance in a land maze.
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Falsafi et al. GABABR complex and spatial memory
INTRODUCTION
Gamma-aminobutyric acid (GABA) is the primary inhibitory
neurotransmitter in the central nervous system and mediates
its effect through two distinct classes of GABA receptors:
the ionotropic (GABAA and GABAC) receptors, which, when
activated produce a rapid and very short-lived inhibition via
chloride currents (Watanabe et al., 2002) and the metabotropic
GABAB receptor, which is responsible for slow but sustained
inhibitory currents (Couve et al., 2000; Bettler et al., 2004).
GABAB receptors are obligatory heterodimers composed
of GABAB1 and GABAB2 subunits, which are required for
agonist binding and G-protein coupling (Robbins et al., 2001).
The receptors are implicated in numerous behaviors and
central nervous system disorders, including epilepsy, depression,
anxiety, panic, and sleep disorders (Bettler et al., 2004).
Molecular diversity of GABAB receptors arise from the two
pharmacologically indistinguishable GABAB1 isoforms (1a and
1b) (Bettler et al., 2004; Pinard et al., 2010) and from potassium
channel tetramerization domain-containing (KCTD) auxiliary
subunits (Schwenk et al., 2010).
Both, GABAB1a and GABAB1b receptor subunits are
expressed in the hippocampus (Liang et al., 2000), where they
can modulate neuronal excitability. It is suggested that GABAB
receptors containing the GABAB1a subunit are primarily located
presynaptically and those with GABAB1b subunits are primarily
postsynaptic (Vigot et al., 2006). However, this distribution
may vary with the brain region and whether the presynaptic
neuron is GABAergic or glutamatergic (Waldmeier et al., 2008).
Heteroreceptors are predominantly found at glutamatergic
boutons, mediating presynaptic inhibition of glutamate release
largely via suppression of Ca2+ currents (Bussières and El
Manira, 1999; Barral et al., 2000; Vigot et al., 2006; Waldmeier
et al., 2008), while postsynaptic receptors activate slow inhibitory
postsynaptic potentials through activation of inwardly rectifying
K+ channels (Fernández-Alacid et al., 2009; Liu et al., 2012).
In addition, GABAB receptors can function as autoreceptors in
interneurons (Waldmeier et al., 2008) and alsomodulate adenylyl
cyclase, through which they influence downstream molecular
pathways (Couve et al., 2000; Bettler et al., 2004).
A substantial body of evidence exists indicating the
modulatory role of GABAB receptors in learning and memory.
Stimulation of GABAB receptors impaired working memory in
the basal forebrain (DeSousa et al., 1994) and medial septum
(Stackman and Walsh, 1994) using double Y- and radial maze.
Conversely, a series of centrally active GABAB receptor blockers
have been shown to improve performance in a host of learning
paradigms, including passive avoidance (Bianchi and Panerai,
1993; Mondadori et al., 1993), active avoidance (Getova and
Bowery, 1998), and radial maze (Helm et al., 2005). However,
Brucato et al. (1996) reported that the antagonist CGP 46381
showed no effect in radial maze and decreased performance in a
water maze (Brucato et al., 1996).
Crosstalk among the neurotransmitter repertoire is common
in the central nervous system. This is made possible through
formation of signaling complexes as a result of receptor assembly
with other receptors or regulatory proteins. As studies so far have
not been addressing GABAB receptor containing complexes as
actors in the MTM, it was the aim of the current study to show
which GABAB-containing receptor complex(es) are involved in
a MTM task, a paradigm for evaluation of spatial learning.
EXPERIMENTAL PROCEDURES
Animals
C57BL/6J (n = 20, male, aged 10–12 weeks, 10 Trained which
are quick learners and were selected from 20 animals and 10
Untrained) mice were used for the study. C57BL/6J mice were
obtained from JANVIER SAS laboratory (France). All mice were
kept and maintained in polycarbonate cages Type II (207 ×
140 × 265mm, Ehret, Austria) filled with autoclaved wood
chips (Ligncell select, Rettenmaier, Austria) in the core unit of
Biomedical Research, Division of Laboratory Animal Science
and Genetics, Medical University of Vienna. The animals were
housed in groups with access to autoclaved Altromin standard
rodent diet (Altromin, Germany) and water ad libitum, and
maintained under standard conditions (ambient temperature of
22 ± 1◦C, relative humidity of 50 ± 10%, light/dark cycle of
14:10, and ventilation with 100% fresh air that resulted in an air
change rate of 15 times per hour). The room was illuminated
with artificial light at an intensity of about 200 l× in 2m
from 5 a.m. to 7 p.m. The experiments were carried out under
a license obtained from the Federal Ministry of Education,
Science and Culture, which includes an ethical evaluation of the
project (Project: BMWF-66.009/0240-II/10b/2009). Housing and
maintenance of animals were in compliance with European and
national regulations (Ghafari et al., 2012a).
Multiple-T-Maze
MTM is one of the spatial learning tasks in which animals
learn to find the goal box based on their memory of previously
visited arms and carried out as described elsewhere (Patil et al.,
2009), with minor modifications. The MTM was constructed
of wood and consisted of a platform with seven choice points,
and dimensions of 150 × 130 × 15 cm and a path width of
8 cm. Before testing, mice were deprived of food for 16 h to
motivate food searching. Tenmice were then placed in a start box
(diameter: 10.5 cm) and allowed to search the reward. The trial
was considered to be completed when the mice either reached
the goal box or failed to find it within 5min. In the goal box, mice
were allowed to consume a small piece of food pellet provided
as a reward. Immediately after each trial, the entire maze was
cleaned with 1% incidin solution (Incidin extraN, Lohmann and
Rauscher, Austria) to remove possible cues. Another 10 mice
were used as untrained controls (yoked controls) that spent
the same time in the MTM without learning performance as
there was no reward in the goal box. After testing, animals
were returned to their cage and given food based on their body
weight (120 g/kg) so as to preserve their weight and keep them
starved for the following day task. Mice were trained for 4 days,
with three trials per day having 20min interval between each
trial. Trials were recorded using computerized tracking/image
analyzer system (video camcorder: 1/3 in. SSAMHR EX VIEW
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HAD coupled to the computational tracking system: TiBe-Split).
The system provides the following parameters: correct or wrong
decision, path length, speed, and latency to reach the goal box.
Six hours following the last training on day 4, animals were
euthanized by neck dislocation. Hippocampi were exstirpated
from the brain within 1min and kept at –80◦C until analyses
(Falsafi et al., 2012).
Sample Preparation
A total of 20 samples (obtained from 10 trained and 10 untrained
mice) were homogenized in ice-cold homogenization buffer
(10mM HEPES, pH 7.5, 300mM sucrose and 1 complete
protease inhibitor tablet [Roche Molecular Biochemicals,
Mannheim, Germany] per 50mL) using an Ultra-Turrax
homogenizer (IKA, Staufen, Germany). The homogenate was
then centrifuged for 10min at 1000 × g, and the pellet was
discarded. The supernatant was subsequently centrifuged at
50,000 × g for 30min in an ultracentrifuge (Beckman Coulter
Optima L-90K), and the resulting pellet was homogenized in
5mL washing buffer (homogenization buffer without sucrose),
incubated on ice for 30min and centrifuged at 50,000 × g for an
additional 30min (Falsafi et al., 2012).
Sucrose Gradient Ultracentrifugation
The plasma membrane purification procedures for the obtained
pellets were performed as previously described with slight
modifications (Ghafari et al., 2012a). Sucrose density gradients
were formed by carefully layering solutions of 700µL of each
of 69, 54, 45, 41, and 37% (w/v) on top of each other.
Membrane pellets were re-suspended in the homogenizing
buffer, and 500µL were layered on top of the tubes that
were then finally filled with the homogenizing buffer. Samples
were ultracentrifuged at 4◦C and 70,000 × g for 3 h. After
centrifugation, the 41% fraction was collected from the sucrose
interface, diluted 10 times with the homogenizing buffer, and
then ultracentrifuged at 4◦C and 100,000 × g for 30min. After




Membrane pellets obtained from the 41% fraction of sucrose
gradient ultracentrifugation were solubilized in extraction buffer
[1.5M 6-aminocaproic acid, 300mM Bis–Tris, pH 7.0] and 10%
Triton X-100 stock solution was added, at a ratio of 1:4, to achieve
a final concentration of 2% Triton X-100, with vortexing every
10min for 1 h. Following solubilization, samples were cleared by
centrifugation at 4◦C and 20,000 × g for 60min. The protein
content was estimated using the BCA protein assay kit (Pierce,
Rockford, IL, USA).
Following mixing of 100µL of the membrane protein
preparation with 16µL BN-PAGE loading buffer [5% (w/v)
Coomassie G250 in 750mM 6-aminocaproic acid], 50µg of
the membrane protein preparations were loaded onto gels.
BN-PAGE was performed in a PROTEAN II xi Cell (BioRad,
Germany) using 4% stacking and 5–18% separating gels. The BN-
PAGE gel buffer contained 500mM 6-aminocaproic acid, 50mM
Bis–Tris, pH 7.0; the cathode buffer contained 50mM Tricine,
15mM Bis–Tris, 0.05% (w/v) Coomassie G250, pH 7.0; and the
anode buffer contained 50mM Bis–Tris, pH 7.0. The voltage was
set to 50V for 1 h followed by 75V for 6 h, and then sequentially
increased to 400V (maximum current 15mA/gel, maximum
voltage 500V) until the dye front reached to the bottom of the
gel (Ghafari et al., 2012a). Native high molecular mass markers
were obtained from Invitrogen (Carlsbad, CA, USA).
Immunoblotting
Membrane proteins were transferred from BN-PAGE to PVDF
membranes. After blocking of the membranes for 1 h with
10% non-fat dry milk in 0.1% TBST (100mM Tris–HCL,
150mM NaCl, pH 7.5, 0.1% Tween 20), mouse anti-GABAB1
(Abcam, ab55051, Cambridge, UK; 1/5000). Goat anti-GABAB1a
(sc-73401/2500), goat anti-MuscarinicM2 (Abcam, ab140473,
Cambridge, UK; 1/3000) and rabbit anti-GABAB2 (Abcam,
ab75838, Cambridge, UK; 1/5000). The antibodies were detected
using horseradish peroxidase-conjugated secondary anti-rabbit
IgG antibodies (Abcam, ab6721, Cambridge, UK; 1/10,000),
anti-Goat IgG antibodies (Abcam, ab6741, Cambridge, UK;
1/5000), Anti-Mouse IgG antibodies (Abcam, 97035, Cambridge,
UK; 1/10,000) Membranes were then developed with the
ECL Plus Western Blotting Detection System (GE Healthcare,
Buckinghamshire, UK). All membranes were stained with
Coomassie blue R-350 (GE Healthcare, Buckinghamshire, UK,
Falsafi et al., 2012). Arbitrary optical densities of immunoreactive
bands were measured by the Image J software program (http://
rsb.info.nih.gov/ij/). Loading controls for the BN-PAGE western
blot were carried out according to Welinder and Ekblad
(Welinder and Ekblad, 2011).
Immunoprecipitation of the GABAB1
Receptor
Total hippocampal membrane fractions were suspended in lysis
buffer containing 1% Triton X100, 150mM NaCl, 1mM EDTA,
50mM Tris-HCl (pH 8.0), 10mM NaF, 10mM Na3VO4 and
protease inhibitor cocktail (Roche, Mannheim, Germany) on a
rotating shaker for 1 h at 4◦C. After centrifugation at 15,300 × g
and 4◦C for 10min, the supernatant was incubated with affinity
purified rabbit antibody against GABAB1 and subsequently
incubated with protein G agarose beads (GEHealthcare, Uppsala,
Sweden) for 4 h at 4◦C with gentle rotation. After washing
five times with the same lysis buffer, proteins bound were
denatured with sample buffer containing 125mM Tris (pH
6.8), 4% SDS, 20% glycerol, 10% beta-mercaptoethanol, and
0.02% bromophenol blue at 95◦C for 3min. Samples were then
loaded onto 10% SDS-polyacrylamide gels, electrophoresed and
subsequently transferred to PVDF membranes and analyzed by
the western blotting as described in the previous subsection
(Ghafari et al., 2012b).
In-gel Digestion of Proteins and Peptides
Bands that were recognized by the corresponding antibodies
against the GABAB1 receptor subunit were picked from the
SDS gel and put into a 1.5mL tube. Gel pieces were initially
washed with 50mM ammonium bicarbonate and then two times
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with washing buffer (50% 100mM ammonium bicarbonate/50%
acetonitrile) each time for 30min with vortexing. An aliquot of
100µL of 100% acetonitrile was added to the tubes to cover the
gel pieces completely and the mixture was incubated for 10min.
Gel pieces were dried using a SpeedVac concentrator. Reduction
of cysteine residues was carried out with 10mM dithiothreitol
(DTT) solution in 100mM ammonium bicarbonate (pH 8.6) for
60min at 56◦C. After discarding the DTT solution, the same
volume of 55mM iodoacetamide (IAA) solution in 100mM
ammonium bicarbonate buffer (pH 8.6) was added and incubated
in darkness for 45min at 25◦C to achieve alkylation of cysteine
residues. The IAA solution was replaced by washing buffer (50%
100mM ammonium bicarbonate/50% acetonitrile) and washed
twice for 15min each time with vortexing. Gel pieces were
washed and dried in 100% acetonitrile followed by dryness in
a SpeedVac. Dried gel pieces were re-swollen with 12.5 ng/µL
trypsin (Promega, Germany) solution reconstituted with 25mM
ammonium bicarbonate. Gel pieces were incubated for 16 h
(overnight) at 37◦C (trypsin). The supernatant was transferred
to new 0.5mL tubes, and peptides were extracted with 50µL of
0.5% formic acid / 20% acetonitrile for 20min in a sonication
bath. This step was repeated two times. Samples in extraction
buffer were pooled in 0.5mL tubes and evaporated in a SpeedVac
concentrator. The volume was reduced to approximately 20µL
and an equal volume of HPLC grade water (Sigma, Germany) was
then added for spectrometric analysis (Ghafari et al., 2012b).
Nano-LC–ESI–CID/ETD-MS/MS
The analysis utilized an Ultimate 3000 HPLC system (Dionex,
Sunnyvale, CA) equipped with a PepMap100 C-18 trap column
(300µm × 5mm) and a PepMap100 C-18 analytic column
(75µm × 150mm). The gradient applied was as follows: A =
0.1% FA in water and B= 0.08% FA in acetonitrile: 4–30% B from
0 to 105min, 80% B from 105 to 110min, and 4% B from 110
to 125min. An HCT ultra ETD II (Bruker Daltonics, Bremen,
Germany) was used to record the peptide spectra over a mass
range of m/z 350–1500 and MS/MS spectra via information-
dependent data acquisition over a mass range of m/z 100–2800.
The MS spectra were repeatedly recorded, followed by four data-
dependent CID MS/MS spectra and four ETD MS/MS spectra
generated from the four highest intensity precursor ions. Active
exclusion of 0.4min following 2 spectra was used to detect low-
abundance peptides. The voltage between the ion spray tip and
spray shield was set to 1500V. Drying nitrogen gas was heated
to 150◦C, and the flow rate was set to 10 L/min. The collision
energy was set automatically according to the mass and the
charge state of the peptides chosen for fragmentation. Multiple
charged peptides were chosen for the MS/MS experiments due to
their good fragmentation characteristics. The obtained MS/MS
spectra were interpreted, and peak lists were generated with
DataAnalysis 4.0 (Bruker Daltonics, Bremen, Germany).
MASCOT searches against the most recent version of the
UniProtKB database were performed using MASCOT 2.2.06
(Matrix Science, London, UK) for protein identification. The
search parameters were set as follows: enzymes selected as
trypsin with a maximum of 2 missing cleavage sites; species
taxonomy limited to mouse; a mass tolerance of 0.2 Da for
peptide tolerance, and 0.2 Da for MS/MS tolerance; an ion
score cutoff below 15; fixed modification of carbamidomethyl
(C); and variable modification of oxidation (M), deamidation
(N, Q), and phosphorylation (S, T, Y). Proteins were positively
identified based on a significant MOWSE score. Following
protein identification, an error-tolerant search was performed
to detect non-specific cleavage and unassigned modifications.
The returned protein identification information was manually
inspected and filtered to confirm the protein identification
lists.
Higher sequence coverage was obtained using Modiro R©
software with the following parameters: the selected enzymes
exhibited two maximum missing cleavage sites; a peptide mass
tolerance of 0.2 Da was selected for peptide tolerance; 0.2 Da
was used as the fragment mass tolerance; and modification
1 of carbamidomethyl (C) and modification 2 of methionine
oxidation were applied. Positive protein identification was first
based on the obtained spectra, and each identified peptide was
subsequently considered significant based on its ion charge
status, b- and y-ion fragmentation quality, ion score (>200)
and significance scores (>80). The protein identifications were
manually inspected and filtered to obtain the confirmed lists of
identified proteins (Ghafari et al., 2012b).
Antibody Shift Assay
For the antibody shift assay (ASA), samples were pre-incubated
for an hour with mouse anti-GABAB1 (Abcam, ab55051,
Cambridge, UK; 1/5000) and rabbit anti-GABAB2 (Abcam,
ab75838, Cambridge, UK; 1/5000), with gentle shaking at 4◦C,
followed by loading the mixture onto the BN gel. The lanes from
the BN gel were cut out and the gel strips were equilibrated for
30min in equilibration buffer [1% (w/v) SDS and 1% (v/v) 2-
mercaptoethanol] with gentle shaking and then briefly rinsed
twice with SDS-PAGE electrophoresis buffer [25mM Tris–HCl,
192mM glycine and 0.1% (w/v) SDS; pH 8.3] and subsequently
by Milli-Q water. SDS-PAGE was performed in a PROTEAN II
xi Cell using 4% stacking gel and 10% separating gel. The gel
strips were run at 12◦C with an initial current of 50V (during
the 1st h). The voltage was subsequently increased to 100V
for the next 12 h (overnight) and then increased to 150V until
the dye front reached the bottom of the gel. The gel was then
further subjected to a western blotting analysis as described
earlier.
Proximity Ligation Assay
Three C57BL/6J mice were anesthetized with 0.3ml/kg
intraperitoneal injection of sodium penthobarbital (Release,
300mg/ml, Wirtschaftsgenossenschaft deutscher Tierärzte eG,
Grabsen, Germany) and perfused intracardially with ice-cold
PBS (0.1M phosphate buffered saline, pH 7.2), containing 0.2%
heparin followed by 4% paraformaldehyde at a pH of 7.4 in
PBS. Brain samples were post-fixed in 4% paraformaldehyde
for 24 h at 4◦C then transferred into a 30% sucrose solution
(in PBS) for 48 h. Brain tissues were embedded with Tissue-
Tek media (OCT compound, Sakura Finetek Europe, The
Netherlands) then immersed in isopentane cooled with dry ice
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and sectioned at 30µmwith a cryostat (Leica CM 3050S,Wetzlar,
Germany).
The Proximity LigationAssay (PLA)was performed according
to the manufacturer’s protocol (O-LINK Bioscience, Uppsala,
Sweden) with slight modifications. Free floating brain slices were
blocked for 30min at room temperature using blocking buffer
supplied with the kit. After blocking, brain slices were incubated
with diluted mouse monoclonal anti-GABAB1 (1:50, Abcam,
Cambridge, UK) and rabbit polyclonal anti-GABAB2 receptor
(1:25 Abcam, Cambridge, UK) primary antibodies for 72 h at
4◦C on a rocking platform. Following incubation with primary
antibodies, slices were washed with wash buffer A (O-LINK
Bioscience, Uppsala, Sweden) and then incubated with rabbit
PLUS and mouse MINUS probes (1:40, O-LINK Bioscience,
Uppsala, Sweden) for 2 h at 37◦C with gentle orbital shaking.
Ligation was performed according to the manufacturer’s protocol
with the exception of the incubation time (45min were used
instead of 30min mentioned in the protocol). DNA polymerase
was diluted (1:20) and incubated for 120min at 37◦C. The rest of
the amplification steps remained unchanged. After amplification,
slices were washed with 1× then 0.01× wash buffer B prepared
according to the recipe supplied in the kit manual. Finally, brain
slices were transferred to glass slides, mounted with Duolink
in Situ Mounting Medium with DAPI (O-LINK Bioscience,
Uppsala, Sweden). Images were acquired with a Zeiss LSM 780
confocal laser scanning microscope (Carl Zeiss GmbH, Jena,
Germany) at 100×magnification keeping all acquisition settings
even through all samples.
Statistical Analyses
Data obtained from MTM and western blotting are presented
as mean ± SD. Data from western blot were analyzed by
unpaired Student’s t-test, while those of MTM were analyzed
using ANOVA with repeated measure. Statistical analysis and
calculations were performed using SPSS for Windows 19.0 and
GraphPad Prism (San Diego, CA, USA).
RESULTS
Behavioral Studies
Mice learned the maze quickly and efficiently Schematic of the
Multiple T maze (MTM) (Figure 1A). Training enabled the
animals to decrease their path length (Figure 1B) across training
days. Latency was relatively unchanged in the first 2 days of
training but was reduced remarkably thereafter (Figure 1C).
Animals also refined their path with each training day as
FIGURE 1 | Performance of C57BL/6J in the Multiple-T maze task: (A) Measured parameters include Path length (B), Latency (C), Speed (D), and
Correct decisions (E). Latency and path length decreased, while speed and correct decision increased across the training days. n = 10; Data are expressed as
mean ± SD and were analyzed by ANOVA repeated measures; ***p < 0.001.
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demonstrated by an increase in the average speed to reach the
goal box (Figure 1D). Errors appear to be left for chance in the
first 2 days of the training but started to decrease thereafter, as
revealed by a significantly increased number of correct decisions
on day 4 (Figure 1E).
Protein-based Studies
To assess the role of GABAB receptors in the MTM task,
exstirpated hippocampi from trained and untrained mice
were subjected to blue native-PAGE followed by western
blotting (BN-PAGE-WB). The analysis revealed the presence
of a complex containing GABAB1 and GABAB2 subunits
at an apparent molecular weight of approximately 600 kDa
(Figure 2A) and 500 kDa (Figure 2B), (range 480–720 kDa).
Subsequent quantitative analysis was made to see the effect
of training on receptor levels. It was found out that a
complex containing the GABAB1 (Figure 2A), and GABAB1a
(Figure 2C), subunit containing receptor complex levels were
significantly increased (p < 0.01) in trained compared to
untrained mice. By contrast, there was no apparent difference
between the two groups when GABAB2 subunit containing
receptor complex levels were considered (Figure 2B). In
addition, based on reports demonstrating direct interaction
between GABAB2 and muscarinic subtype 2 (M2) receptors
through receptor assembly at the plasma membrane (Boyer
et al., 2009), an attempt was also made to detect and quantify
M2 containing receptor complex levels using BN-PAGE-WB.
M2 was detected as having an apparent molecular weight
of approximately 600 kDa, but its levels did not exhibit any
significant difference between trained and untrained animals
(Figure 3).
Assays used for analysis of proteins showed the presence of
the two subunits within the complex. The ASA is often used to
verify the co-existence of a protein in a complex. The binding of
specific antibodies to a target protein causes a shift of the whole
target protein complex on the BN-PAGE by the added mass of
the antibody. A corresponding mass shift of a protein complex,
therefore, is indicative of the presence of the target protein in the
complex. In this assay, antibodies specific for B1 and B2 subunits
shifted the complex to higher apparent molecular weights, with
the discrete increments most likely reflecting assembly of these
subunits into GABAB receptors.
ASA was performed to provide additional evidence for co-
assembly of the two subunits in order to form functional
FIGURE 2 | Western blot analysis of training-induced changes in levels of GABAB1 and GABAB1a (A,C) and GABAB2 (B) subunits containing receptor
complex in C57BL/6J mice, the number of mice are shown in each bar (A) there were samples from 9 untrained and 10 trained animals: membrane
preparations obtained as described in the method section were subjected to BN-SDS-PAGE followed by Western blotting. Subunits migrated in a blue
native gel as a GABAB receptor complex at anapparent molecular weight of 500 and 600 kDa (Range, 480–720 kDa). Levels were determined measuring arbitrary
optical densities of immunoreactive bands using the Image G software; data are expressed as mean ± SD and analyzed by unpaired student’s t-test; *p < 0.01
compared to untrained mice.
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FIGURE 3 | Western blot analysis of training-induced changes in levels
of muscarinic type 2 receptor containing complex in C57BL/6J mice:
membrane preparations obtained as described in the method section
were subjected to BN-PAGE followed by western blotting. Complexes
migrated in a blue native gel as a muscarinic type 2 containing receptor
complex at an apparent molecular weight of 600 kDa (Range, 480–720 kDa).
Levels were determined measuring arbitrary optical densities of
immunoreactive bands using the Image G software. Data are expressed as
mean ± SD and analyzed by student’s t-test.
receptors (Figure 4). The assay revealed that the band in the
control (without incubation of an antibody) (upper band) was
shifted toward a high molecular weight when incubated with
anti-GABAB1 antibody (central band) and with anti-GABAB2
antibody (lower band).
Immunoprecipitation was carried out using an antibody
against the GABAB1 subunit (also used for Western blotting,
see above) and the subunit was shown to co-precipitate with
GABAB2. the GABAB1 receptor subunit was detected at an
apparent molecular weight of approximately 100 kDa (Figure 5).
Mass spectrometry following in-gel digestion of bands from the
corresponding SDS-PAGE showed the presence of GABAB1,
GABAB2, Calcium Calmodulin kinase II (CaMKII α and
β subunits), Glutamate receptor 1 (GluA1), and Glutamate
receptor 2 (GluA2). Data from mass spectrometry indicating
the total sequence coverage for the individual proteins in
the immunoprecipitate are provided in Table 1. Peptides
Peptides used for the protein identifications are given in the
Supplementary Table 1.
PLA
Evidence for the presence of the two GABAB subunits
within the complex was provided by the PLA (Figure 6).
The assay produced a typical number of discrete fluorescent
spots, demonstrating the co-localization of both GABAB1 and
GABAB2 subunits within the complex in the hippocampal
formation.
DISCUSSION
Spatial learning and memory is largely dependent on the
hippocampus and is mediated by persistent changes in neuronal
structure and activity. GABAB receptors are localized in the
perisynaptic areas of dendritic spines as well as in the dendritic
shafts, which enable them to regulate synaptic inputs (Bettler
and Tiao, 2006). As a result, changes in the activity of GABAB
receptors are critical for controlling neuronal activity and
cognitive functioning (Bowery et al., 2002).
The use of BN-PAGE allows subsequent immunoblotting of
strongly hydrophobic membrane proteins as receptors and native
receptor complexes including high molecular weight material
(Kang et al., 2009). The GABAB1 and GABAB2 complexes could
therefore be detected in their native forms. The present study
alluded to the fact that trained mice displayed an enhanced
performance in MTM, a spatial learning task, (Figure 1) and
this performance was paralleled by an increased expression of a
GABAB1/1a containing receptor complex.
Most of the evidence relating GABAB receptors to learning
and memory came out of studies using pharmacological ligands.
Accordingly, antagonists appear to enhance cognition inmajority
of the cases (Bianchi and Panerai, 1993; Mondadori et al.,
1993; Staubli et al., 1999; Helm et al., 2005), but have either
neutral or inhibitory effect in a few cases (Brucato et al., 1996).
The pattern for agonists is variable, ranging from impairment
(DeSousa et al., 1994; Nakagawa and Takashima, 1997; Cryan
et al., 2004; Zarrindast et al., 2004) through facilitation (Georgiev
et al., 1988; Saha et al., 1993) to no effect (Cryan et al., 2004;
Li et al., 2013). Possible explanations for these discrepancies
could be that: (i) behavioral paradigms that assess learning and
memory differentially involve stress- or anxiety-related behavior;
therefore, the underlying neurobiology and pharmacology are
not identical (Sharma et al., 2010) large species and strain
differences exist in these paradigms (Sharma et al., 2010) dose
administered (Li et al., 2013) and outcomes assessed (learning
or retention) (Cryan et al., 2004) could be different: or (iv) as
selectivity of these ligands for the two isoforms of GABAB1 is
unclear, they can differentially bind to one of the two isoforms,
thereby producing different effects. As no antibody against
GABAB1b was available, herein the GABAB1a isoform was
determined which was significantly increased in the GABAB1-
containing complex paralleling retrieval in the MTM.
Subunit phosphorylation appears to regulate the surface
dynamics of GABAB receptors. Phosphorylation at S867 by
calcium/calmodulin-dependent protein kinase II (CaMKII)
triggers endocytosis (Guetg et al., 2010), whereas protein
kinase A (PKA) mediated phosphorylation at S892 stabilizes
the receptor at the cell surface (Couve et al., 2002). The
degree of activation of NMDA receptors, however, appears
to control phosphorylation status of S783. Whilst transient
NMDA activation leads to phosphorylation by AMP kinase
and stabilization of the receptor, prolonged stimulation causes
dephosphorylation by PP2A, which serves as a signal to promote
degradation (Terunuma et al., 2010, 2014). Phosphorylation of
S867 by CaMKII is detectable only in the GABAB1b subunit
(Guetg et al., 2010), which mostly resides in the dendrites, in
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FIGURE 4 | Antibody shift assay to show the presence of GABAB subunits in receptor complexes: membrane preparations were incubated with and
without an antibody against the respective subunits of GABAB1 and GABAB2 and subjected to BN-SDS-PAGE. Complexes incubated with the respective
antibody shifted toward the high molecular weight (middle and lower bands) compared to controls (upper band).
FIGURE 5 | Immunoprecipitation using an antibody against the GABABl
subunit run on an SDS-PAGE. The resulting gel showed the pattern of
probable receptor complex composition containing GABAB1, GABAB2,
Calcium/calmodulin-dependent protein kinase [CaMKII α and β isoforms,
Glutamate receptor type1 (GluA1), and 2 (GluA2)]. Mass spectrometry was
carried out for identification of receptor proteins picking the bands shown by
arrows.
contrast to the GABAB1a subunit, which efficiently penetrates
spines (Vigot et al., 2006). In addition, S783Amutation increased
the expression of postsynaptic GABAB receptors by blocking
receptor degradation, and this was accompanied by an increase
in excitatory synapses and elevated surface AMPA receptors
(Terunuma et al., 2014). And indeed, CaMKII and AMPA
receptors GluA1 and GluA2 were co-immunoprecipitating with
GABAB1.
Mice with S783A mutation displayed significant alterations in
contextual fear learning and reduced long-term spatial memory
in Barnes’s maze, effects thought to result from enhanced
expression of postsynaptic GABAB receptors (Terunuma et al.,
2014). In the hippocampus, GABAB1a/2 receptors are located
mainly presynaptically, whereas GABAB1b/GABAB2 receptors
are located primarily postsynaptically (Vigot et al., 2006), and
CGP 35348, a GABAB receptor antagonist with significantly
higher affinity for post- vs. presynaptic receptors, is shown to
enhance cognition (Olpe et al., 1993; Staubli et al., 1999). In
TABLE 1 | Mass spectrometric identification of the GABAB1 subunit
containing receptor complex.
Receptor Accession Length Mass (Da) Sequence
number coverage (%)
GABAB1 Q9WV18 960 108 23
GABAB2 Q80T41 940 105 17
CaMKII Alpha P11798 478 54 21
CaMKII Beta P28652 542 60 12
GRIA1 P23818 907 101 3
GRIA2 P23819 883 98 10
Bands picked from SDS-PAGE and subjected to MS/MS analysis.
the present study, an increase in GABAB1 containing, but not
GABAB2 containing receptor complexes and this finding was
paralleling performance in the MTM task. Findings from the
current study suggest that the increased GABAB1a isoform-
containing subunit involves a presynaptic mechanism. Since
increased complex levels were noted following training of mice in
anMTM task, the observation is consistent with the physiological
role of GABAB1a containing receptors in ensuring that plasticity
processes are maintained in the dynamic range (Gassmann and
Bettler, 2012). Training did not have any appreciable effect on
levels of GABAB2 containing receptor complexes as well as
other receptors that interact with this subunit such as the M2
receptors. This suggests that although the GABAB2 subunit
of the complex is required for G-protein coupling, receptor-
mediated effects are largely dependent onGABAB1 subunit of the
complex.
The maximal distance between the secondary antibodies in
PLA is slightly larger than the distance between flurophores in
energy transfer technologies, allowing validation of themolecular
proximity of endogenous proteins in vitro or ex vivo (Schwenk
et al., 2009; Navarro et al., 2013). The PLA produced a signal
representing co-localization of the two subunits within the
hippocampus providing further evidence for the presence of both
subunits in a complex.
It is known that the GABAB receptor is a heterodimer
receptor, but so far mass spectrometric evidence for a
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FIGURE 6 | Detection of GABAB1-GABAB2 receptor complexes by “in situ” Proximity Ligation Assay: Brain slices were incubated with primary
antibodies for the two subunits. Slices were then incubated with plus and minus probes, ligated, and amplified. After that, slices were mounted and images were
acquired through confocal microscopy. Representative images showing the GABAB1-GABAB2 receptor complex (A) negative control with no primary antibody (B)
counterstained nuclei with DAPI in mouse hippocampus. Each signal represents the proximity/probable interaction of GABAB1 with GABAB2 receptors. The arrows
indicate examples of signals. Confocal microscope images acquired at 100× magnification. Scale bar 10µm.
complex containing the subunits from mouse brain is missing.
Immunoprecipitation followed by mass spectrometry produced
evidence for the presence of a protein complex containing
both subunits along with proteins involved in the glutamatergic
signaling system. Methodologically, nano-LC–ESI–MS/MS was
applied for identification of receptor subunits and unambiguous
identification with high sequence coverage was obtained. This
was achieved through in-gel digestion with trypsin and the use of
two mass spectrometric principles, the combination of CID and
ETD.
The co-precipitation of the GABAB1 receptor with proteins
involved in glutamatergic signaling indicates that the two systems
interact with each other through formation of a signaling
complex. Indeed, previous co-immunoprecipitation followed
by pull down assay showed that CaMKII associates with the
GABAB1 receptor in mouse brain. This association may enable
CaMKII to phosphorylate GABAB receptor at S867 and trigger
endocytosis (Guetg et al., 2010). This observation is consistent
with our finding of detecting CaMKII within the receptor
complex.
Taken together, data presented herein demonstrate that
training leads to increased levels of GABAB1/1a—containing
receptor complexes but not GABAB2—containing receptor
complexes in mouse hippocampus. The presence of these
subunits in the complex is unequivocally confirmed using
several biochemical methods including BN-PAGE, ASA, PLA,
and immunoprecipitation followed by mass spectrometry. The
findings are relevant for previous studies and the design of future
studies on GABAB-receptors and spatial memory.
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